HPV

HPV

Cervical specimens collected in PreservCyt® Solution using an endocervical brush/spatula or collected in SurePath Preservative Fluid using a cervical broom

PreservCyt or SurePath

Refrigerated

2-30C for 6 months

The test utilizes amplification of target DNA by the Polymerase Chain Reaction (PCR) and nucleic acid hybridization for the detection of 14 high-risk (HR) HPV types in a single analysis. The test specifically identifies types HPV16 and HPV18 while concurrently detecting the rest of the high risk types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68).

The BBRL HPV Test detects DNA of the high-risk types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68. This test does not detect DNA of HPV low-risk types (e.g., 6, 11, 42, 43, 44) since there is no clinical utility for testing of low-risk HPV types34.

The test for detection of human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68 is not recommended for evaluation of suspected sexual abuse.

The test a qualitative in vitro diagnostic test for the detection of Human Papillomavirus in cervical specimens collected by a clinician using an endocervical brush/spatula and placed in the ThinPrep Pap Test PreservCyt® Solution or using a cervical broom and placed in SurePathTM Preservation Fluid.

Human Papillomavirus